Background: Adherence to breast cancer (BC) screening is a key element to ensure effectiveness
Introduction
Breast cancer (BC) is the most common non-skin cancer in women in the majority of western countries (1) . Although mortality has been progressively declining in developed countries, the same is not true for the developing ones, such as Brazil (2) . Since there are no measures with proven effectiveness applicable to all women to reduce the incidence of the disease, early diagnosis through proper screening is the only means towards reduction of BC associated mortality.
An effective screening program relies largely on the target population's adherence to it, which includes two components: the proportion of the target women that perform screening and the frequency in which they attend to the program. The latter is one of the cornerstones of a successful screening program, since regular intervals between exams -which should be shorter than the mean lead time -are required to guarantee early BC detection (3) .
Some studies, conducted mostly in the UK and USA, have assessed women's adherence to mammographic screening and associated factors. The main factors related to worse compliance to screening were lower educational level, positive family history, current tobacco use, hormone replacement therapy (HRT), previous negative mammographic experiences, insurance status, and lower socio-economic level, assessed either individually or using data regarding women's neighborhood (4) (5) (6) (7) (8) (9) (10) . Obesity was associated with lower adherence in white, but not in black women (11) . Effect of age was inconsistent among studies, with younger women presenting either worse (5, 6) or better adherence (9) . Conversely, studies in specific populations showed conflicting results: while Schumacher et al. have found similar factors for worst adherence in American Indian and Alaska native people (6), Graves et al. did not observe any association between the aforementioned factors and screening adherence in a sample of data collected with research purposes. Moreover, none of them evaluated a sample from a developing country, in which different factors might play a role in screening compliance. Finally, few papers focused on underserved women, where barriers to screening are possibly different from the ones observed in the general population. In 2004, we started a screening project to test the effectiveness of an early diagnosis and treatment program for underserved women in Southern Brazil (13) . The objective of this study was to evaluate screening adherence and related factors in women who have performed at least their first mammogram after an invitation for a screening program.
Materials and methods

Study design, setting and sample
We conducted a prospective cohort study with the participants of a screening and early treatment program, the Porto Alegre Breast Health Intervention Cohort (Núcleo Mama Porto Alegre -NMPOA). The full description of this project has been published elsewhere (13) . Briefly, the project aims to test the effectiveness and cost-effectiveness of an early detection and treatment program for underserved women between the ages of 40 and 69 years, through yearly breast clinical exam and mammography. The initiative derives from a partnership between a private institution (Associação Hospitalar Moinhos de Vento) and public sector (Porto Alegre's City Health Department), in which the major contribution of the latter is to assist in the active search of participants, which is carried out by lay community health workers from Every month, women who had their last visit 12 months before are reminded of their annual appointment by the thoroughly trained community workers through home visits.
Although participants may spontaneously come to the BHU in order to schedule their appointment, the program is based on active search, which already starts at the 12 th month after the participants' last mammogram (that is, not only after they are overdue). A breast clinical exam (performed by a trained nurse or breast surgeon) and mammography are carried out in all attending participants. Women with abnormal mammograms are referred for further evaluation (e.g., diagnostic mammogram with compression and/or magnification, ultrasound, fine-needle or core biopsy) in the same facility where screening takes place. All women are assessed for family or personal history of breast, colorectal and/or ovarian cancer using a simple 7-question instrument, FHS-7, which has been validated in this population (14) . If the family history is suggestive of a hereditary BC syndrome, the patient is referred to a clinical geneticist for further evaluation (15) . The program also includes nutritional support for overweight women and psychological follow-up for all BC patients. All these clinical visits (genetic assessment, nutrition and psychology) take place at the same location where breast cancer screening occurs, the NMPOA center. Women between 40 and 69 years were invited to the screening cohort, and participants in the age range of 15 to 39 years were sensitized to the importance of BC early detection and advised to attend their BHU once a year for clinical follow-up. When these women reach the age of 40, they are visited by the community workers, who invite them to join the screening cohort.
The recruitment was based on two main mechanisms. The first one relied on the aid of the community workers, who announced the project in the community and to women attending the BHUs for any reason. These women were examined by family physicians (previously trained in breast examination and instructed about the importance of early diagnosis), being referred to the NMPOA center subsequently. The second mechanism was based on community efforts conducted by our team, from which a breast surgeon, a nurse and a nurse technician visited some of the communities in pre-determined days (where a large advertising effort was made in order to increase the community's participation), examined the attending women and referred them to NMPOA center whenever indicated. Globally, these procedures achieved a 25% recruitment rate from the target age group (40-69 years) in the selected area.
Currently, more than 4,200 women have been enrolled in the screening cohort. In the present analysis, we included all participants who had joined the cohort at least 18 months before the dataset was prepared for this report.
Data collection and measurements
All participants responded to a standardized questionnaire applied by the attending nurse or physician during enrollment, which included socio-economic and clinical data. All appointments are registered in a computerized system, which keeps track of all clinical and imaging exam data.
The variables included in the analysis of potential predictors of screening compliance were the following: educational level, income, number of children, high genetic risk, history of oral contraceptive (OC) use and HRT, previous breast biopsy, smoking habits, regular breast selfexam, age, body mass index (BMI) and enrollment during community efforts. Age was analyzed both as a continuous and a dichotomous variable, in which the cut-point was 50 years old. This cut-point was set seeing that the Brazilian Ministry of Health screening recommendation is for women 50 years or older. Since we did not have individual income data available for a significant amount of the sample, we used the neighborhood income level as a proxy for individual income. Genetic risk was determined by review of the personal and family history of cancer and estimation of the lifetime risk of developing breast cancer measured by three different mathematic models (the Gail and Tyrer-Cuzick models and the Claus tables (16-18)).
Women with an estimated lifetime-risk (adjusted to age) of developing breast cancer < 0.2 were considered in the average risk group (similar to population risk). Those with an estimated lifetime risk of developing breast cancer ≥ 0.2 using either the Gail and Tyrer-Cuzick models or the Claus tables and those presenting phenotypic criteria for a hereditary breast cancer predisposition syndrome by pedigree analysis were considered at high lifetime risk for developing breast cancer (referred as high genetic risk hereafter).
Adherence to the program was considered as a mean interval between exams of 18 months or less. Although the recommended screening interval in the project is 12 months, we defined an 18-month interval as acceptable, since some previous clinical trials have also used an 18-month screening interval (19, 20) . Furthermore, other papers also evaluating adherence to mammography have used even larger intervals (2 years) (21) (22) (23) (24) . Moreover, considering the mean sojourn time of the disease in the population in this age range, the 18 months interval has a performance marginally inferior to 12 months. We used the average interval time between
Reported performance of breast self-examination (BSE) was 55%, and 36% were current or former smokers. Complete baseline profile is displayed in Table 1 
Adherence and its predictors
The percentage of participants who had a mean interval between screening rounds of 18 months or less was 57.6%. When the cut-point evaluated was increased to 24 months, this proportion was 71.0%.
The effect of predictors on adherence, considered as a mean interval of 18 months or less between mammograms, is displayed on Table 2 . The most important independent predictors were high genetic risk (RR = 1.25, 95% CI = 1.11 -1.40), illiteracy (RR = 0.77, 95% CI = 0.67 -0.90), history of OC use (RR = 1.11, 95% CI = 1.04 -1.19) and number of children, where a parity of 5 or greater yielded a 11% smaller probability of adherence (95% CI 4% -17%) when compared to a parity of 2 or less. The history of smoking habits generated diverse results: while current smoking was associated with a substantial smaller probability of adherence (RR = 0.82, 95% CI = 0.77 -0.88), participants who were former smokers had a higher adherence (RR = 1.10, 95% CI 1.01 -1.19). Age, BMI and the habit of performing regular breast-self examination had no effect on adherence. The adherence seen in this project should be evaluated in light of the cultural, social and economic reality of these women. The regions where these women come from have a mean monthly family income of R$ 531.00 (US$ 301.00). These data, taken into account together with the low educational level of the women that were included in this sample, support that an adherence of 57% in a 18 months interval is a significant achievement.
Moreover, some cultural issues that might play a role here should me mentioned. First, there might be a cultural difference in understanding the impact of preventive and early detection interventions (22, 27, 28) , especially in a country such as Brazil, where there is not a structured BC screening program, and thus women are historically not used to perform regular mammography or other early detection measures. Second, certain cultures are more fatalistic about cancer and perceive fewer benefits from screening (29) , which is, in the authors' perception, an important issue in Brazil, especially in lower socio-economic classes. Finally, in many of these women, concerns regarding its own health care are frequently neglected because of more urgent needs, such as childcare and providing food.
The variables associated with adherence in this sample fall into three categories. The first is socio-economic level, measured by education level and income, and also represented by the proxies OC use and number of children, depicting family planning, which is in turn directly The second category, healthy lifestyle behaviors, had conflicting results: while regular BSE had no relation to adherence, smoking had an interesting effect. Previous papers have already demonstrated that non-smokers were more likely to adhere to screening that current smokers (6, 31) . In our study, we split the category of non-smokers in never and ex-smokers, and observed a higher adherence in the latter. Although it might look paradoxical that current and previous smoking were associated with lower and higher adherence, respectively, we believe that a person who used to smoke and quits might be more concerned about his/her own health that a person who never started smoking. We could not find an explanation for the lack of association between BSE and adherence. 
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Copyright © 2010 American Association for Cancer Research lower adherence. In contrast to these studies, age had no influence in our analysis. This probably reflects the educational efforts from our group, who reinforces to all women, regardless of their age, the importance of screening through mammography between the ages of 40 and 69 years.
The main strengths of our study are the sample used and the way that data was collected. While the majority of other studies analyzed the general population, our focus on underserved women expands the body of knowledge regarding BC screening attendance to a group of women in which BC is usually more devastating, considering the more difficult access to the best treatments available and consequent worse disease course. Secondly, the primary collection of data, in opposition to many of the other studies in the area, which used either administrative data for predictors assessment or interview response do determine adherence, ensures greater data accuracy. Moreover, our longitudinal and prospective data collection is more powerful in adherence evaluation than cross-sectional data, used in the majority of studies in the field. Our large sample, with a good representation from the geographical area that originated this study population, is also a methodological strength in our study.
Some limitations should be mentioned. Our sample is not population based, that is, considering the enrollment process, some women were probably not aware of the project, what configures a self-selection bias. This might overestimate the adherence to screening in similar populations, but we do not believe that the impact on the predictors' evaluation is large.
Moreover, the objective of this research was to evaluate the adherence to screening in women who came at least once to mammography, an approach which will always incur in self-selection bias in some extent. Also, some important information was not collected, such as a better and more direct assessment of socio-economic condition. The evaluation of wages using neighborhood income level is a possible problem, especially when the neighborhood is The results from our research point to two possible pathways to increase overall BC screening in underserved populations similar to the one we studied. The first one would be a closer monitoring for women with risk factors for worse adherence, with elaboration of focused strategies to increase compliance. However, the good average adherence seen in this screening program (71%, if we consider the two-year interval as acceptable) suggests that the greater efforts that ought to be made are to encourage women to initiate screening. The low recruitment rate achieved in the project (25%) reinforces this idea: although it is possible that some of the remainder women in this area are being screened for BC in other centers (e.g., through private insurance), it is most likely that the majority of women in this population are not performing mammography in a regular basis.
Public health policies towards breast cancer early diagnosis in Brazil have not been implemented according to the increased number of new cases a year (almost 50,000 women).
Mortality rates are steadily increasing for the last 20 years. Thus, pilot studies as the one presented here should be encouraged in attempt to design a national program for early detection. The identification of population-specific predictors of adherence to breast cancer screening programs is essential to concentrate efforts to reduce those situations associated with decreased adherence, and thus, maximize the effectiveness of breast cancer downstaging programs. 
